217 related articles for article (PubMed ID: 21711968)
21. Expression, localization, and significance of vascular permeability/vascular endothelial growth factor in nasal polyps.
Gosepath J; Brieger J; Lehr HA; Mann WJ
Am J Rhinol; 2005; 19(1):7-13. PubMed ID: 15794068
[TBL] [Abstract][Full Text] [Related]
22. Increased expression of IL-19 in the epithelium of patients with chronic rhinosinusitis and nasal polyps.
Pace E; Scafidi V; Di Bona D; Siena L; Chiappara G; Ferraro M; La Grutta S; Gallina S; Speciale R; Ballacchino A; Bachert C; Bousquet J; Gjomarkaj M
Allergy; 2012 Jul; 67(7):878-86. PubMed ID: 22583192
[TBL] [Abstract][Full Text] [Related]
23. Nitric oxide metabolites as biomarkers for follow-up after chronic rhinosinusitis surgery.
Deroee AF; Naraghi M; Sontou AF; Ebrahimkhani MR; Dehpour AR
Am J Rhinol Allergy; 2009; 23(2):159-61. PubMed ID: 19401041
[TBL] [Abstract][Full Text] [Related]
24. Increased activation and differentiated localization of native and phosphorylated STAT3 in nasal polyps.
Linke R; Pries R; Könnecke M; Bruchhage KL; Böscke R; Gebhard M; Wollenberg B
Int Arch Allergy Immunol; 2013; 162(4):290-8. PubMed ID: 24157808
[TBL] [Abstract][Full Text] [Related]
25. Expression of acidic fibroblast growth factor and basic fibroblast growth factor in nasal polyps.
Kim HJ; Jung HH; Lee SH
Acta Otolaryngol; 2006 Jun; 126(6):600-5. PubMed ID: 16720444
[TBL] [Abstract][Full Text] [Related]
26. Gene expression profiling of nasal polyps associated with chronic sinusitis and aspirin-sensitive asthma.
Stankovic KM; Goldsztein H; Reh DD; Platt MP; Metson R
Laryngoscope; 2008 May; 118(5):881-9. PubMed ID: 18391768
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of surfactant protein A in chronic rhinosinusitis.
Lee HM; Kang HJ; Woo JS; Chae SW; Lee SH; Hwang SJ
Laryngoscope; 2006 Feb; 116(2):328-30. PubMed ID: 16467728
[TBL] [Abstract][Full Text] [Related]
28. Increased exhaled nitric oxide and its oxidation metabolism in eosinophilic chronic rhinosinusitis.
Takeno S; Taruya T; Ueda T; Noda N; Hirakawa K
Auris Nasus Larynx; 2013 Oct; 40(5):458-64. PubMed ID: 23489830
[TBL] [Abstract][Full Text] [Related]
29. Analysis of syndecan-1 and TGF-beta expression in the nasal mucosa and nasal polyps.
Go K; Ishino T; Nakashimo Y; Miyahara N; Ookubo T; Takeno S; Hirakawa K
Auris Nasus Larynx; 2010 Aug; 37(4):427-35. PubMed ID: 20047808
[TBL] [Abstract][Full Text] [Related]
30. Expression of neutrophil gelatinase-associated lipocalin in nasal polyps.
Woo HJ; Min JK; Bai CH; Song SY; Kang HJ; Lee HM; Kim YD
Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1182-6. PubMed ID: 19015448
[TBL] [Abstract][Full Text] [Related]
31. Expression of hypoxia-inducible factor 1alpha in the nasal polyps by real-time RT-PCR and immunohistochemistry.
Chien CY; Tai CF; Ho KY; Kuo WR; Chai CY; Hsu YC; Wang LF
Otolaryngol Head Neck Surg; 2008 Aug; 139(2):206-10. PubMed ID: 18656716
[TBL] [Abstract][Full Text] [Related]
32. Mucosal expression of nerve growth factor and brain-derived neurotrophic factor in chronic rhinosinusitis.
Coffey CS; Mulligan RM; Schlosser RJ
Am J Rhinol Allergy; 2009; 23(6):571-4. PubMed ID: 19958603
[TBL] [Abstract][Full Text] [Related]
33. Differential expression of Toll-like receptor pathway genes in chronic rhinosinusitis with or without nasal polyps.
Zhang Q; Wang CS; Han DM; Sy C; Huang Q; Sun Y; Fan EZ; Li Y; Zhou B
Acta Otolaryngol; 2013 Feb; 133(2):165-73. PubMed ID: 23157229
[TBL] [Abstract][Full Text] [Related]
34. The role of superantigens in chronic rhinosinusitis with nasal polyps.
Wang M; Shi P; Chen B; Zhang H; Jian J; Chen X; Wang Z; Zhang D
ORL J Otorhinolaryngol Relat Spec; 2008; 70(2):97-103. PubMed ID: 18408407
[TBL] [Abstract][Full Text] [Related]
35. Transient receptor potential vanilloid type 4 channel expression in chronic rhinosinusitis.
Bhargave G; Woodworth BA; Xiong G; Wolfe SG; Antunes MB; Cohen NA
Am J Rhinol; 2008; 22(1):7-12. PubMed ID: 18284852
[TBL] [Abstract][Full Text] [Related]
36. Role of interferon-γ-producing t cells in the pathogenesis of chronic rhinosinusitis with nasal polyps associated with staphylococcal superantigen.
Cho KS; Kim CS; Lee HS; Seo SK; Park HY; Roh HJ
J Otolaryngol Head Neck Surg; 2010 Oct; 39(5):600-5. PubMed ID: 20828526
[TBL] [Abstract][Full Text] [Related]
37. Expression of extracellular matrix metalloproteinase inducer in nasal polyps.
Lee JH; Chung SW; Park IH; Lee SH; Lee SH; Lee HM
Am J Rhinol Allergy; 2010; 24(6):127-31. PubMed ID: 20969816
[TBL] [Abstract][Full Text] [Related]
38. Group II subfamily secretory phospholipase A2 enzymes: expression in chronic rhinosinusitis with and without nasal polyps.
Liu Z; Lu X; Wang H; You XJ; Gao QX; Cui YH
Allergy; 2007 Sep; 62(9):999-1006. PubMed ID: 17578498
[TBL] [Abstract][Full Text] [Related]
39. Low SPINK5 expression in chronic rhinosinusitis.
Fruth K; Goebel G; Koutsimpelas D; Gosepath J; Schmidtmann I; Mann WJ; Brieger J
Laryngoscope; 2012 Jun; 122(6):1198-204. PubMed ID: 22570283
[TBL] [Abstract][Full Text] [Related]
40. Pro-resolution mediator lipoxin A4 and its receptor in upper airway inflammation.
Shimizu S; Ogawa T; Seno S; Kouzaki H; Shimizu T
Ann Otol Rhinol Laryngol; 2013 Nov; 122(11):683-9. PubMed ID: 24358628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]